e-learning
resources
London 2016
Monday, 05.09.2016
Prevalence, prognosis, and risk factors of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Risk of myocardial infarction (MI) associated with acute exacerbations of COPD (AECOPD): Effects of exacerbation frequency
Kieran Rothnie (London, United Kingdom), Kieran Rothnie, Hana Müllerová, Liam Smeeth, Neil Pearce, Ian Douglas, Jennifer Quint
Source:
International Congress 2016 – Prevalence, prognosis, and risk factors of COPD
Session:
Prevalence, prognosis, and risk factors of COPD
Session type:
Poster Discussion
Number:
3107
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Kieran Rothnie (London, United Kingdom), Kieran Rothnie, Hana Müllerová, Liam Smeeth, Neil Pearce, Ian Douglas, Jennifer Quint. Risk of myocardial infarction (MI) associated with acute exacerbations of COPD (AECOPD): Effects of exacerbation frequency. Eur Respir J 2016; 48: Suppl. 60, 3107
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
COPD patients admitted in ICU for acute exacerbation: Impact of exacerbation factors on prognosis
Source: International Congress 2016 – Dealing with the complexity of critically-ill patients
Year: 2016
Characteristics and prognostic factors associated with cardiovascular (CV) comorbidity in COPD patients hospitalized for acute exacerbation (AECOPD)
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Outcome of patients following hospitalization with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) , with and without cardiovascular risk factors
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
Predictors of readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013
Early readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is associated with high mortality
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Acute exacerbations of COPD: The influence of comorbidities and chronic medication on mortality and exacerbation rate
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015
Effect of severity of exacerbations of COPD and hospitalised pneumonia on risk of myocardial infarction
Source: International Congress 2017 – COPD: risk factors and prognosis
Year: 2017
Risk factors for another hospitalization in COPD patients hospitalized for exacerbation
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Impact of not planned readmissions due to acute exacerbations of chronic obstructive pulmonary disease
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
Cardiovascular risk assessment in COPD patients with severe exacerbation
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Co-morbidity and hospitalization rate in patients (pts) with acute exacerbation (AE) of COPD
Source: International Congress 2015 – Different data in COPD
Year: 2015
Cardiovascular medications and mortality in patients hospitalised with acute exacerbations of COPD
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Characterization of readmissions in patients hospitalized with COPD exacerbation
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
In hospitalized COPD exacerbation (COPDE) patients a 30-day readmission is associated with a progressive increased risk of mortality
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
Gender differences of echocardiographic characteristics in patients with acute exacerbation of COPD
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015
Rehospitalizations for an acute exacerbation among patients with COPD
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Survival in COPD patients with hospitalization due to exacerbation
Source: International Congress 2014 – Longitudinal studies of respiratory disease
Year: 2014
Gender differences in hospitalized patients with acute exacerbation of COPD
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Acute exacerbations of chronic obstructive pulmonary disease: Is it acute exacerbations of chronic cardiopulmonary disease?
Source: International Congress 2014 – Comorbidities
Year: 2014
Determinants of re-hospitalizations due to acute exacerbation of COPD
Source: International Congress 2017 – What is new in COPD diagnosis and classification?
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept